Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Viemed Healthcare Inc
NASDAQ:VMD

Watchlist Manager
Viemed Healthcare Inc Logo
Viemed Healthcare Inc
NASDAQ:VMD
Watchlist
Price: 9.015 USD -1.15% Market Closed
Market Cap: $345.6m
Write Note Create Alert Ask AI

Wall St Price Targets

VMD Price Targets Summary
Viemed Healthcare Inc

Wall Street analysts forecast VMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VMD is 13.26 USD with a low forecast of 11.11 USD and a high forecast of 15.75 USD.

VMD Lowest Forecast
Wall Street Target
$11.11
23% Upside
VMD Average Forecast
Wall Street Target
$13.26
47% Upside
VMD Highest Forecast
Wall Street Target
$15.75
75% Upside
Lowest Forecast
Price Target
11.11 USD
23% Upside
Average Forecast
Price Target
13.26 USD
47% Upside
Highest Forecast
Price Target
15.75 USD
75% Upside
Viemed Healthcare Inc Competitors:
Price Targets

Revenue
Forecast

24% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
17%
Average Beat
24% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
17%
Average Beat

Over the last 5 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 2 years is 23%.

What are analyst estimates?

Gross Profit
Forecast

20% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
20% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Viemed Healthcare Inc

Operating Income
Forecast

-1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Viemed Healthcare Inc

Pre-Tax Income
Forecast

2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Viemed Healthcare Inc

Net Income
Forecast

-5% / Year
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
23%
Average Beat
-5% / Year
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
23%
Average Beat

Over the last 5 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 2 years is 54%.

What are analyst estimates?

Continue VMD Research

Summary
VMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
VMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VMD stock valuation using valuation multiples.
Wall St Estimates
VMD price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Viemed Healthcare Inc listings:
TSX • CAD
VMD
 F • EUR
VIJ
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is VMD's stock price target?
Price Target
13.26 USD

According to Wall Street analysts, the average 1-year price target for VMD is 13.26 USD with a low forecast of 11.11 USD and a high forecast of 15.75 USD.

What is the Revenue forecast for Viemed Healthcare Inc?
Projected CAGR
23%

Over the last 5 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 2 years is 23%.

What is the Net Income forecast for Viemed Healthcare Inc?
Projected CAGR
54%

Over the last 5 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 2 years is 54%.

Back to Top
ALPHA SPREAD
Follow us
Join 353,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett